Telomir Pharmaceuticals (TELO) Institutional Ownership $2.65 +0.00 (+0.15%) As of 01:53 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Telomir Pharmaceuticals (NASDAQ:TELO)Number ofInstitutional Buyers(last 12 months)18TotalInstitutional Inflows(last 12 months)$3.98MNumber ofInstitutional Sellers(last 12 months)0 Get TELO Insider Trade Alerts Want to know when executives and insiders are buying or selling Telomir Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TELO Institutional Buying and Selling by Quarter Remove Ads Telomir Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025Nuveen Asset Management LLC24,990$103K0.0%N/A0.084% 2/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,699$44K0.0%+279.4%0.036% 2/17/2025Gotham Asset Management LLC6,770$28K0.0%N/A0.023% 2/17/2025Bank of America Corp DE14,713$61K0.0%+283.9%0.049% 2/14/2025Northern Trust Corp151,628$625K0.0%+211.5%0.510% 2/14/2025Transce3nd LLC28,803$119K0.0%N/A0.097% 2/13/2025Barclays PLC29,959$123K0.0%+326.9%0.101% 2/13/2025Wells Fargo & Company MN10,044$41K0.0%+458.3%0.034% 2/12/2025Geode Capital Management LLC413,677$1.71M0.0%+73.3%1.390% 2/12/2025JPMorgan Chase & Co.41,444$171K0.0%+1,096.4%0.139% 2/11/2025Corebridge Financial Inc.9,613$40K0.0%+273.8%0.032% 2/11/2025Virtu Financial LLC14,959$62K0.0%N/A0.050% 2/6/2025Charles Schwab Investment Management Inc.46,406$191K0.0%+327.7%0.157% 2/4/2025Bank of New York Mellon Corp72,295$298K0.0%+40.8%0.244% 1/30/2025 Rhumbline Advisers8,600$35K0.0%+105.9%0.029% 11/19/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/16/2024Geode Capital Management LLC238,737$1.53M0.0%+259.8%0.806% 11/15/2024Barclays PLC7,018$45K0.0%+325.1%0.024% 11/15/2024State Street Corp36,094$232K0.0%+99.1%0.122% 10/21/2024Suncoast Equity Management51,194$329K0.0%+109.9%0.173% 8/15/2024Beaird Harris Wealth Management LLC14,623$70K0.0%+212.9%0.049% 7/26/2024Bank of New York Mellon Corp50,165$241K0.0%N/A0.169% 5/2/2024Suncoast Equity Management24,391$126K0.0%N/A0.082% (Data available from 1/1/2016 forward)Remove Ads TELO Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TELO shares? During the previous two years, 18 institutional investors and hedge funds held shares of Telomir Pharmaceuticals. The most heavily invested institutionals were Geode Capital Management LLC ($1.71M), Northern Trust Corp ($625K), Suncoast Equity Management ($329K), Bank of New York Mellon Corp ($298K), State Street Corp ($232K), Charles Schwab Investment Management Inc. ($191K), and JPMorgan Chase & Co. ($171K).Learn more on TELO's institutional investors. Which institutional investors have been buying Telomir Pharmaceuticals stock? Of the 18 institutional investors that purchased Telomir Pharmaceuticals stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Geode Capital Management LLC ($347.32K), Northern Trust Corp ($102.95K), Bank of New York Mellon Corp ($71.10K), Suncoast Equity Management ($51.19K), JPMorgan Chase & Co. ($37.98K), Charles Schwab Investment Management Inc. ($35.56K), and Barclays PLC ($33.68K). How much institutional buying is happening at Telomir Pharmaceuticals? Institutional investors have bought a total of 821,679 shares in the last 24 months. This purchase volume represents approximately $3.98M in transactions. Related Companies Oruka Therapeutics Major Shareholders Revance Therapeutics Major Shareholders Kamada Major Shareholders Sana Biotechnology Major Shareholders SNDL Major Shareholders Upstream Bio Major Shareholders Rapport Therapeutics Major Shareholders Stoke Therapeutics Major Shareholders REGENXBIO Major Shareholders Mereo BioPharma Group Major Shareholders This page (NASDAQ:TELO) was last updated on 4/11/2025 by MarketBeat.com Staff From Our PartnersTrump’s Secret WeaponHave you looked at the stock market recently? Millions of investors are scrambling trying to figure out what's...American Alternative | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredFeds Just Admitted It—They Can Take Your CashHere’s the cold truth: If your money is sitting idle in a bank account, it’s vulnerable. That’s why thousan...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Telomir Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Telomir Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TELO Stock Free TELO Stock Alerts